Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2026-03-26 @ 3:16 PM
Ignite Modification Date:
2026-03-26 @ 3:16 PM
NCT ID:
NCT07430332
Eligibility Criteria:
Inclusion Criteria:
* Stage 1 Type 1 Diabetes
* Screening OGTT with impaired or loss of first phase insulin secretion but no dysglycemia to suggest stage 2 or stage 3 type 1 diabetes
Exclusion Criteria:
* History of anaphylaxis or allergies to GLP-1 receptor agonists
* Already on a GLP-1 receptor agonist
* History of bariatric surgery
* Personal or family history of cancer such as medullary thyroid cancer
* Personal history of pancreatitis or pathogenic variants associated with increased risk of pancreatitis
* Severe hypoglycemia within 3 months of study enrollment
* Pregnant, breastfeeding, or the intention of becoming pregnant or not using adequate contraceptive measures
* Adult individuals with BMI \< 18.5 kg/m2 and pediatric participants with BMI \< 5th percentile
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
12 Years
Maximum Age:
70 Years
Study:
NCT07430332
Study Brief:
Protocol Section:
NCT07430332